Table 3. Results with selected cytochrome P450 inhibitors used in this study.
Entry | Compound | Survival at 7 days (%) | Function and CYP450 class inhibited | |||
---|---|---|---|---|---|---|
Adult | Schistosomula | |||||
5 μM | 10 μM | 5 μM | 10 μM | |||
1 | Miconazole | 57 | 10 | 72 | 22 | antifungal CYP51 |
2 | Sertaconazole | 95 | 15 | 65 | 6 | |
3 | Sulconazole | 100 | 50 | 90 | 56 | |
4 | Fenticonazole | 75 | 50 | 92 | 79 | |
5 | Econazole | 100 | 55 | 87 | 66 | |
6 | Oxiconazole | 100 | 60 | 89 | 71 | |
7 | Tioconazole | 100 | 85 | 86 | 82 | |
8 | Bifoconazole | 100 | 100 | 80 | 79 | |
9 | Butoconazole | 100 | 80 | 77 | 60 | |
10 | Clotrimazole | n.d. 1 | 100 | 97 | 90 | |
11 | Ketoconazole | n.d. | 100 | 98 | 97 | |
12 | Fluconazole | 100 | 100 | 98 | 94 | |
13 | Posaconazole | 100 | 100 | 94 | 88 | |
14 | Triadimenol | 100 | 100 | 99 | 99 | |
15 | Prochloraz | 100 | 100 | 94 | 82 | |
16 | Sulfaphenazole | 100 | 100 | 99 | 93 | antibacterial CYP2C9 |
17 | Piperonyl butoxide | 100 | 100 | 100 | 100 | pesticide CYP6D1 |
18 | Abiraterone acetate | 100 | 100 | 100 | 100 | prostate cancer CYP17A1 |
19 | Anastrozole | 100 | 100 | 100 | 100 | breast cancer CYP19A1 |
20 | Letrozole | 100 | 100 | 100 | 100 | |
21 | Aminoglutethimide | 100 | 100 | 100 | 100 | |
22 | Dafadine | 100 | 100 | 100 | 100 | CYP27A1 |
1n.d., not determined.